Necrotizing fasciitis in a patient treated with etanercept for dermatomyositis

Rheumatology International

Volumn 29, Issue 4, 2009, Pages 463-466

  Choi, Kyoung Hwa ^a   Yoo, Wan Hee ^a  

^a Chonbuk National University Medical School   (South Korea)

Author keywords

Dermatomyositis; Etanercept; Necrotizing fasciitis

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; ETANERCEPT; METHOTREXATE; PREDNISOLONE; STEROID; VANCOMYCIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DEBRIDEMENT; DERMATOMYOSITIS; DRUG WITHDRAWAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; NECROTIZING FASCIITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; ANTIRHEUMATIC AGENTS; DEBRIDEMENT; DERMATOMYOSITIS; FASCIITIS, NECROTIZING; FEMALE; HUMANS; IMMUNOGLOBULIN G; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; TREATMENT OUTCOME;

EID: 59449084087     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-008-0695-4     Document Type: Article

References (19)

1. JP Callen 2000 Dermatomyositis Lancet 355 53 57 10.1016/S0140-6736(99) 05157-0
2. K Danko A Ponyi T Constantin G Borgulya G Szegedi 2004 Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases Medicine (Baltimore) 83 35 42 10.1097/01.md.0000109755.65914.5e
3. H Sprott M Glatzel BA Michel 2004 Treatment of myositis with etanercept (Enbrel), a recombinant human soluble fusion protein of TNF-alpha type II receptor and IgG1 Rheumatology (Oxford) 43 524 526 10.1093/rheumatology/keh062
4. GJ Hengstman FH van den Hoogen P Barrera MG Netea A Pieterse LB van de Putte 2003 Successful treatment of dermatomyositis and polymyositis with anti-tumor-necrosis-factor-alpha: preliminary observations Eur Neurol 50 10 15 10.1159/000070852
5. GJ Hengstman FH van den Hoogen BG van Engelen 2004 Treatment of dermatomyositis and polymyositis with anti-tumor necrosis factor-alpha: longterm follow-up Eur Neurol 52 61 63 10.1159/000079547
6. P Efthimiou S Schwartzman LJ Kagen 2006 Possible role for tumour necrosis factor inhibitors in the treatment of resistant dermatomyositis and polymyositis: a retrospective study of eight patients Ann Rheum Dis 65 1233 1236 10.1136/ard.2005.048744
7. Maynor M, Kardon E, Talavera F, Weiss E, Halamaka J, Feied C Necrotizing fasciitis. eMedicine. Available at http://www.emedicine.com/emerg/topic332.htm. [Accessed 12 May 2005]
8. A McEntegart HA Capell 2002 Necrotizing fasciitis in a patient with rheumatoid arthritis Rheumatology (Oxford) 41 828 829 10.1093/rheumatology/41.7. 828
9. N Hashimoto H Sugiyama K Asagoe K Hara O Yamasaki Y Yamasaki 2002 Fulminant necrotising fasciitis developing during long term corticosteroid treatment of systemic lupus erythematosus Ann Rheum Dis 61 848 849 10.1136/ard.61.9.848
10. I Marie E Hachulla P Chérin MF Hellot S Herson H Levesque 2005 Opportunistic infections in polymyositis and dermatomyositis Arthritis Rheum 53 155 165 10.1002/art.21083
11. IE Lundberg M Dastmalchi 2002 Possible pathogenic mechanisms in inflammatory myopathies Rheum Dis Clin North Am 28 799 822 10.1016/S0889- 857X(02)00025-X
12. LM Pachman MR Liotta-Davis DK Hong TR Kinsella EP Mendez JM Kinder 2000 TNFalpha-308A allele in juvenile dermatomyositis: association with increased production of tumor necrosis factor alpha, disease duration, and pathologic calcifications Arthritis Rheum 43 2368 2377 10.1002/1529-0131(200010)43: 10<2368::AID-ANR26>3.0.CO;2-8
13. M Tateyama I Nagano M Yoshioka K Chida S Nakamura Y Itoyama 1997 Expression of tumor necrosis factor-alpha in muscles of polymyositis J Neurol Sci 146 45 51 10.1016/S0022-510X(96)00280-8
14. CV Oddis LG Rider AM Reed N Ruperto HI Brunner B Koneru International Myositis Assessment and Clinical Studies Group 2005 International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies Arthritis Rheum 52 2607 2615 10.1002/art.21291
15. ME Weinblatt JM Kremer AD Bankurst KJ Bulpitt RM Fleischmann RI Fox 1999 A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate N Engl J Med 340 253 259 10.1056/NEJM199901283400401
16. JM Bathon RW Martin RM Fleischmann JR Tesser MH Schiff EC Keystone 2000 A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis N Engl J Med 343 1586 1593 10.1056/NEJM200011303432201
17. AT Chan V Cleeve TJ Daymond 2002 Necrotising fasciitis in a patient receiving infliximab for rheumatoid arthritis Postgrad Med J 78 47 48 10.1136/pmj.78.915.47
18. SM Sultan Y Ioannou K Moss DA Isenberg 2002 Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality Rheumatology (Oxford) 41 22 26 10.1093/rheumatology/41.1.22
19. P Jarrett M Rademaker M Duffill 1997 The clinical spectrum of necrotizing fasciitis. A review of 15 cases Aust N Z J Med 27 29 34